Monday, March 14, 2016 10:12:57 PM
A capital raise carried out without a discount at 3.30 AUD.
http://www.asx.com.au/asxpdf/20160315/pdf/435v33fzf94sv4.pdf
Lagoda Investment Management bought the new shares and now almost owns 10 % of the company. It seems they can't get enough. Very encouraging and significant.
http://www.asx.com.au/asxpdf/20160315/pdf/435v52hvvsmffr.pdf
And a roll out of the implant is now a fact.
http://www.asx.com.au/asxpdf/20160315/pdf/435v52hvvsmffr.pdf
With price negotiations pending we still have some uncertainty but it is nothing compared to what longs have endured over the past years.
Clinuvel is grossly undervalued. EPP alone will propel the pps to a much higher level. Label extensions, Vitiligo, pediatric EPP and the cream will do unimaginable things the the pps.
And most importantly: 1000 of patients with a broad variety of horrible disorders are about to benefit from this wonder drug that has such a huge future.
GLTA
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM